Prestige Biologics Co., Ltd. (KOSDAQ: 334970)

Prestige Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 10, 2024	Jun 30, 2024	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	375,774	245,391	272,542	184,546	453,181	-
Market Cap Growth	11.55%	-9.96%	47.68%	-59.28%	-	-
Enterprise Value	519,310	378,645	369,331	283,846	447,789	-
Last Close Price	6110.00	3990.00	4460.00	3020.00	9600.00	-
PE Ratio	-	-8.32	-6.63	-3.14	-10.84	-
PS Ratio	172.56	113.13	156.11	11855.95	140.44	-
PB Ratio	5.24	3.42	2.73	1.57	4.24	-
P/FCF Ratio	-14.55	-14.55	-4.52	-1.55	-3.68	-
P/OCF Ratio	-29.40	-29.40	-10.98	-5.41	-17.60	-
EV/Sales Ratio	239.42	174.57	211.55	18235.34	138.77	-
EV/EBITDA Ratio	-17.06	-17.06	-11.68	-9.89	-19.54	-
EV/EBIT Ratio	-11.33	-11.33	-9.22	-7.75	-16.69	-
EV/FCF Ratio	-30.79	-22.45	-6.13	-2.39	-3.64	-
Debt / Equity Ratio	2.41	2.41	1.60	1.01	0.73	-19.80
Debt / FCF Ratio	-10.26	-10.26	-2.66	-1.00	-0.63	-1.69
Asset Turnover	0.01	0.01	-	0.00	0.03	-
Inventory Turnover	0.89	0.89	-	0.00	0.14	0.00
Quick Ratio	0.34	0.34	0.53	0.54	1.59	0.10
Current Ratio	0.60	0.60	0.79	0.92	1.93	0.17
Return on Equity (ROE)	-34.26%	-34.26%	-	-44.30%	-74.70%	-226.09%
Return on Assets (ROA)	-7.02%	-7.02%	-	-9.85%	-13.05%	-23.09%
Return on Capital (ROIC)	-8.28%	-8.28%	-	-10.87%	-15.88%	-34.78%
Earnings Yield	-7.85%	-11.97%	-14.47%	-26.94%	-8.69%	-
FCF Yield	-4.49%	-6.87%	-22.11%	-64.36%	-27.17%	-
Buyback Yield / Dilution	-23.38%	-4.43%	-13.35%	-16.43%	-25.46%	-11.46%
Total Shareholder Return	-23.38%	-4.43%	-13.35%	-16.43%	-25.46%	-11.46%

Source: S&P Capital IQ. Standard template. Financial Sources.